Entrada Therapeutics Inc (TRDA)
17.60
+0.32
(+1.85%)
USD |
NASDAQ |
Dec 20, 16:00
17.60
0.00 (0.00%)
After-Hours: 20:00
Entrada Therapeutics Profit Margin (Quarterly): -71.70% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 34.10% |
| Vertex Pharmaceuticals Inc | 37.71% |
| Sarepta Therapeutics Inc | 7.19% |
| Regenxbio Inc | -246.3% |
| Edgewise Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.06% |
| Return on Assets | 10.56% |
| Return on Invested Capital | 17.06% |
| Operating Margin (Quarterly) | -110.7% |
| Return on Net Operating Assets | 47.77% |